Pioglitazone and Metformin Extended-Release Tablets and SymlinPen
Determining the interaction of Pioglitazone and Metformin Extended-Release Tablets and SymlinPen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: metformin / pioglitazone
Brand name: Actoplus Met, Actoplus Met XR
Synonyms: Metformin and pioglitazone, Pioglitazone and Metformin
Generic Name: pramlintide
Brand name: SymlinPen 120, SymlinPen 60, Symlin
Synonyms: SymlinPen (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pioglitazone and Metformin Extended-Release Tablets-SymlinPen 120
- Pioglitazone and Metformin Extended-Release Tablets-SymlinPen 60
- Pioglitazone and Metformin Extended-Release Tablets-Symmetrel
- Pioglitazone and Metformin Extended-Release Tablets-SymPak II
- Pioglitazone and Metformin Extended-Release Tablets-Sympazan
- Pioglitazone and Metformin Extended-Release Tablets-Symproic
- SymlinPen-Pioglitazone and Metformin Tablets
- SymlinPen-Pioglitazone Hydrochloride
- SymlinPen-Pioglitazone Tablets
- SymlinPen-Piperacillin
- SymlinPen-Piperacillin and tazobactam
- SymlinPen-Piperacillin and tazobactam Intravenous